Trial intelligence / Profile preview

Androderm ABPM Study in Hypogonadal Men

NCT04320745Phase 4Completed

Sponsor
Allergan
Start
May 2020
Primary completion
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of testosterone in Hypogonadism, sponsored by Allergan. Started May 2020; status: completed.

02

Drugs

testosterone
03

Conditions

Hypogonadism

Beyond the preview

Go deeper on NCT04320745.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04320745.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call